Evidence map›Paper›PMID 42500673›Full record

ReviewFrontiers in immunology2026

Targeting macrophage metabolism: mechanisms, cellular crosstalk and implications in obesity-associated metabolic diseases.

Chensi Yao, Wei Zheng, Yamei Jin, Jiahao Sheng, Mengjiao Kang, Jijuan Zhong, Min Li, Liyun Duan, Xiao Yuan

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chensi YaoDepartment of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Wei ZhengDepartment of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Yamei JinDepartment of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Jiahao ShengThe First Clinical Medical School, Zhejiang Chinese Medical University, Hangzhou, China.
Mengjiao KangThe First Clinical Medical School, Zhejiang Chinese Medical University, Hangzhou, China.
Jijuan ZhongDepartment of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Min LiMolecular Biology Laboratory, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Liyun DuanThe First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Xiao YuanDepartment of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity and its associated metabolic disorders constitute a prominent public health challenge. Diverse environmental and metabolic cues trigger alterations in macrophage metabolism, thereby influencing their functional phenotypes. Due to their phenotypic plasticity, macrophages play beneficial roles in tissue homeostasis, yet they also contribute to the progression of metabolic diseases. Consequently, beyond systemic chronic low-grade inflammation, greater attention should be directed toward immunometabolic dysfunction in metabolic tissues during obesity and its related diseases. This review summarizes the functional phenotypes and metabolic characteristics of macrophages, with an emphasis on how tissue niches influence macrophage function in the context of various obesity-related metabolic diseases. Enhanced understanding of the interplay between macrophages and metabolic target organs/tissues may provide novel therapeutic strategies for managing obesity and associated metabolic disorders.

Indexed as

MacrophagesMetabolic DiseasesObesityAnimalsCell CommunicationHumansInflammationMacrophage Activationinflammationmacrophagesmetabolismobesity-associated metabolic diseasespolarizationreprogramming

Identifiers

PMID42500673
PMCPMC13395690

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.